Clinical trial
Intensive Glycemic Control and Skeletal Health Study
NCT00324350 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00324350 |
|---|---|
| Title | Intensive Glycemic Control and Skeletal Health Study |
| Official title | Intensive Glycemic Control and Skeletal Health Study - Ancillary Study to the Action to Control Cardiovascular Risk in Diabetes Trial (ACCORD-BONE) |
| Acronym | ACCORD-BONE |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Cardiovascular Diseases, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease |
| Intervention type | Drug |
| Interventions | hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents |
| Enrollment | 7,287 |
| Start date | Oct 1, 2003 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | May 11, 2006 |
| Last update posted | Oct 5, 2012 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: